Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation

Leukemia and Lymphoma

Volumn 30, Issue 3-4, 1998, Pages 367-380

  Tormo, Mar ^a   Tari, Ana Maria ^a   Mcdonnell, Timothy J ^a   Cabanillas, Fernando ^a   Garcia Conde, Javier ^b   Lopez Berestein, Gabriel ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Antisense; Apoptosis; Bcl 2; Follicular lymphoma

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CONTROLLED STUDY; DNA CLEAVAGE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031816031     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057548     Document Type: Article

References (32)

1. Nuñez., G., London, L., Hockenbery, D., Alexander, M., McKearn, J. and Korsmeyer, S. J. (1990). Deregulated BCL-2 gene expression selectively prolongs survival of growth factors-deprived hemopoietic cell lines. Journal of Immunology, 144, 3602-3610.
2. Reed, J. C. (1995). Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematology Oncology Clinics of North America, 9, 451-473.
3. Hockenbery, D., Nuñez., G., Milliman, C., Schreiber, R. D. and Korsmeyer, S. J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336.
4. McDonnell, T. J., Deane, N., Platt, F. M., Nuñez, G., Jaeger, U., McKearn, J. P. and Korsmeyer, S. J. (1989). Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
5. McDonnell, T. J. and Korsmeyer, S. J. (1991). Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18). Nature, 349, 254-256.
6. Oltvai, Z. N., Milliman, C. L. and Korsmeyer, S. J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74, 609-619.
7. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G. and Thompson, C. B. (1993). BCL-X, a BCL-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
8. 1, and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285-291.
9. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evans, G. I. and Guild, B. C. (1995). Induction of apoptosis by the Bcl-2 homologue Bak. Nature, 374, 733-736.
10. Kicfer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomel, L. D. and Barr. P. J. (1995). Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature, 374, 736-739.
11. Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P. and Craig, R. W. (1993). MCL-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proceedings of National Academy of Sciences USA, 90, 3516-3520.
12. Lin, E. Y., Orlofsky, A., Berger, M. S. and Prystowsky, M. B. (1993). Characterization of Al. a novel hemopoietic-specific early-response gene with sequence similarity to BCL-2. Journal of Immunology, 151, 1979-1988.
13. Pearson, G. R., Luka, J., Petti, L., Sample, J., Birkenback, M., Braun, D. and Kieff, E. (1987). Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology, 160, 151-161.
14. Neilan, J. G., Lu, Z., Afonso, C. L., Kutish, G. F., Sussman, M. D. and Rock, D. L. (1993). An African Swine fever virus with similarity to the protooncogene BCL-2 and the Epstein-Barr virus gene BHRF1. Journal of Virology, 67, 4391-4394.
15. Sato, T., Hanada, M., Bodrug, S., Iric, S., Iwama, N., Boise, L., Thompson, C., Fong, L., Golemis, E., Wang, H. G. and Reed, J. C. (1994). Interactions among members of bcl-2 protein analyzed with a yeast two-hybrid system. Proceedings of National Academy of Sciences USA, 91, 9238-9242.
16. Yin, X.-M., Oltvai, Z. N. and Korsmeyer, S. J. (1994). BHI and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature, 369, 321-323.
17. Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E. and Croce, C. M. (1985). The t(14:18) chromosome translocation involved in B-cell neoplasms result from mistakes in VDJ joining. Science, 229, 1390-1393.
18. Graninger, W. B., Seto, M., Boutain, B., Goldman, P. and Korsmeyer, S. J. (1987). Expression of bcl-2 and bcl-2-lg fusion transcripts in normal and neoplastic cells. Journal of Clinical Investigations, 80, 1512-1515.
19. Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, C. W., Epstein, A. L. and Korsmeyer, S. J. (1985). Cloning the chromosomal breakpoint of t(14:18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell, 41, 899-906.
20. Tsujimoto, Y., Ikegaki, N. and Croce, C. M. (1987). Characterization of the protein product of bcl-2. the gene involved in human follicular lymphoma. Oncogene, 2, 3-7.
21. Tari, A. M., Tucker, S. D., Deisseroth, A. and Lopez-Berestein, G. (1994). Liposomal delivery of methylphosphonate oligodeoxynucleotides in chronic myelogenous leukemia. Blood, 84, 601-607.
22. Tari, A. M., Neamati, N., Andreeff, M. and Lopez-Berestein, G. Liposomal delivery of P-ethoxy antisense oligodeoxynucleotides in chronic myelogenous leukemia. In: Targeting of Drugs: Strategies for oligonucleotide and gene delivery in therapy, G. Gregoriadis (ed.). Plenum Press, in press.
23. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin. H. K., Liebermann, D. A., Hoffman, B. and Reed, J. C. (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
24. Vaux, D., Cory, S. and Adams, J. (1988). Bcl-2 promotes hemapoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-442.
25. Reed, J. C., Cuddy, M., Haldar, S., Croce, C., Nowell, P. and Makover, D. (1990). Bcl-2-mediated tumorigenicity in a human T-lymphoid cell line: synergy with c-myc and inhibition by Bcl-2 antisense. Proceedings of National Academy of Sciences USA, 87, 3660-3664.
26. Blagosklonny, M. V. and Neckers, L. (1995). The role of Bcl-2 protein and autocrine growth factors in a human follicular lymphoma-derived B cell line. European Cytokine Network, 6, 21-27.
27. Cotter, F. E., CJ, P., Hall, P., Pocock, C., Al Mahdi, N., Cowell, J. K. and Morgan, G. (1994). Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Oncogene, 9, 3049-3055.
28. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B. and Korsmeyer, S. J. (1995). Multiple bcl-2 family members demonstrate selective dimerization with bax. Proceedings of National Academy of Sciences USA, 92, 7834-7838.
29. Vogelstein, B. and Kinzler, K. W. (1992). p53 function and dysfunction. Cell, 70. 523-526.
30. Miyashita, T. and Reed, J. C. (1995). Tumor suppressor p53 ia a direct transcriptional activator of the human BAX gene. Cell, 80, 293-299.
31. Fukuchi, K., Tomoyasu, S., Watanabe, H., Kaetsu, S., Tsuruoka, N. and Gomi, K. (1995). Iron deprivation results in an increase in p53 expression. Biological Chemistry Hoppe-Seyler, 376, 627-630.
32. Kitada, S., Takayama, S., De Riel, K., Tamaka, S. and Reed, J. C. (1994). Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Research and Development, 4, 71-79.